首页> 美国卫生研究院文献>Scientific Reports >Genome-wide identification of target genes for miR-204 and miR-211 identifies their proliferation stimulatory role in breast cancer cells
【2h】

Genome-wide identification of target genes for miR-204 and miR-211 identifies their proliferation stimulatory role in breast cancer cells

机译:对miR-204和miR-211的靶基因进行全基因组鉴定确定其在乳腺癌细胞中的增殖刺激作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MiR-204 and miR-211 (miR-204/211) share the same seed site sequence, targeting many of the same genes. Their role in cancer development remains controversial, as both cell proliferative and suppressive effects have been identified. This study aimed to address the relationship between the two structurally similar microRNAs (miRs) by examining their target genes in depth as well as to reveal their contribution in breast cancer cells. Genome-wide pathway analysis with the dysregulated genes after overexpression of either of the two miRs in MCF-7 breast cancer cell identified the “Cancer”- and “Cell signaling”-related pathway as the top pathway for miR-204 and miR-211, respectively. The majority of the target genes for both miRs notably comprised ones that have been characterized to drive cells anti-tumorigenic. Accordingly, the miRs induced the proliferation of MCF-7 and MDA-MB-231 cells, judged by cell proliferation as well as colony forming assay. Tumor suppressors, MX1 and TXNIP, were proven to be direct targets of the miRs. In addition, a high association was observed between miR-204 and miR-211 expression in breast cancer tissue. Our results indicate that miR-204/211 serve to increase cell proliferation at least in MCF-7 and MDA-MB-231 breast cancer cells by downregulating tumor suppressor genes.
机译:MiR-204和miR-211(miR-204 / 211)共享相同的种子位点序列,靶向许多相同的基因。由于已经确定了细胞的增殖和抑制作用,它们在癌症发展中的作用仍存在争议。这项研究旨在通过深入研究两个靶标基因来探讨两个结构相似的microRNA(miR)之间的关系,并揭示它们在乳腺癌细胞中的作用。在MCF-7乳腺癌细胞中两个miR的任何一个过表达后,利用基因失调的基因组进行的全基因组通路分析确定了与“癌症”和“细胞信号传导”相关的通路是miR-204和miR-211的主要通路, 分别。两种miR的大多数靶基因都特别包含已被表征为驱动细胞具有抗致瘤性的那些。因此,根据细胞增殖以及集落形成分析判断,miRs诱导了MCF-7和MDA-MB-231细胞的增殖。事实证明,抑癌药MX1和TXNIP是miR的直接靶标。另外,在乳腺癌组织中的miR-204和miR-211表达之间观察到高度关联。我们的结果表明,miR-204 / 211至少通过下调肿瘤抑制基因来增加MCF-7和MDA-MB-231乳腺癌细胞的增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号